Cargando…

The effects of tumor size and postoperative radiotherapy for patients with adult low‐grade (WHO grade II) infiltrative supratentorial astrocytoma/oligodendroglioma: A population‐based and propensity score matched study

BACKGROUND: The update of 2018 NCCN guidelines (central nervous system cancers) recommended the risk classification of postoperative patients diagnosed as adult low‐grade (WHO grade II) infiltrative supratentorial astrocytoma/oligodendroglioma (ALISA/O) should take tumor size into consideration. Mor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Dong‐Dong, Deng, Xiang‐Yang, Zheng, Dong‐Dong, Gu, Cheng‐Hui, Yu, Li‐Sheng, Xu, Shang‐Yu, Li, Dan‐Dong, Fang, Jun‐Hao, Yin, Bo, Sheng, Han‐Song, Lin, Jian, Zhang, Xiao‐Lei, Zhang, Nu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308075/ https://www.ncbi.nlm.nih.gov/pubmed/30378290 http://dx.doi.org/10.1002/cam4.1853

Ejemplares similares

Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019)

The role of postoperative radiotherapy in pediatric patients with grade II intracranial ependymomas: a population-based, propensity score-matched study
por: Deng, Xiangyang, et al.
Publicado: (2018)

Naturopathic Treatment of Grade III Oligodendroglioma With Progression to Grade IV Isocitrate Dehydrogenase (IDH)-Mutant Astrocytoma and the Development of Spinal Gliomatosis
por: Terrani, Kristina F, et al.
Publicado: (2023)

Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
por: Zhao, Binghao, et al.
Publicado: (2022)

Oligodendrogliomas tend to infiltrate the frontal aslant tract, whereas astrocytomas tend to displace it
por: Landers, M. J. F., et al.
Publicado: (2023)

Conventional and emerging treatments of astrocytomas and oligodendrogliomas
por: Kessler, Tobias, et al.
Publicado: (2022)

Clinical management of grade III oligodendroglioma
por: Simonetti, G, et al.
Publicado: (2015)

Computational Analysis of IDH1, IDH2, and TP53 Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas
por: Bendahou, Mohammed Amine, et al.
Publicado: (2020)

The Expression of Leptin and Its Receptor During Tumorigenesis of Diffuse Gliomas such as Astrocytoma and Oligodendroglioma- Grade II, III and IV (NOS)
por: Vokuda, Ramya S, et al.
Publicado: (2019)

Personalizing age‐specific survival prediction and risk stratification in intracranial grade II/III ependymoma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Low‐grade gangliogliomas in adults: A population‐based study
por: Lin, Xiaoning, et al.
Publicado: (2020)

Ability of Radiomics in Differentiation of Anaplastic Oligodendroglioma From Atypical Low-Grade Oligodendroglioma Using Machine-Learning Approach
por: Zhang, Yang, et al.
Publicado: (2019)

Magnetic Resonance Spectroscopy for Prediction of Grades of Diffusely Infiltrating Intracranial Astrocytomas
por: Abu, Obaida, et al.
Publicado: (2020)

Trends in intracranial meningioma incidence in the United States, 2004‐2015
por: Lin, Dong‐Dong, et al.
Publicado: (2019)

Low-Grade Oligodendroglioma of the Pineal Region: Case Report
por: Lamis, Fabricio Correa, et al.
Publicado: (2015)

Grading of oligodendroglioma in dogs based on magnetic resonance imaging
por: Amphimaque, Bénédicte, et al.
Publicado: (2022)

Long-term molecular changes in WHO grade II astrocytomas following radiotherapy
por: Yue, Wei-Ying, et al.
Publicado: (2012)

Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma
por: Lin, Han, et al.
Publicado: (2021)

Postoperative functional status in patients with supratentorial superficial low-grade glioma
por: Zhang, Ji, et al.
Publicado: (2017)

Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013)

Fetuin‐A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high‐grade astrocytomas
por: Nangami, Gladys N., et al.
Publicado: (2016)

Surgery for Patients With Spontaneous Deep Supratentorial Intracerebral Hemorrhage: A Retrospective Case-Control Study Using Propensity Score Matching
por: Zheng, Jun, et al.
Publicado: (2016)

World Health Organization Grade II Oligodendroglioma Occurring after Successful Treatment for Childhood Acute Lymphoblastic Leukemia
por: Yoon, Sang-In, et al.
Publicado: (2016)

EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2013)

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
por: Bleehen, N. M., et al.
Publicado: (1981)

PATH-15. PROTEOMIC SIGNATURES PREDICT GRADE IN PEDIATRIC AND YOUNG ADULT INFILTRATIVE ASTROCYTOMAS
por: Graham, Richard T, et al.
Publicado: (2020)

The feasibility of MRI texture analysis in distinguishing glioblastoma, anaplastic astrocytoma and anaplastic oligodendroglioma
por: Teng, Yuen, et al.
Publicado: (2022)

Metachronous spinal metastases from supratentorial anaplastic astrocytoma
por: Raheja, Amol, et al.
Publicado: (2015)

Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases
por: Kim, Jo-Heon, et al.
Publicado: (2019)

Immunodetection of Pyruvate Carboxylase Expression in Human Astrocytomas, Glioblastomas, Oligodendrogliomas, and Meningiomas
por: Gondáš, Eduard, et al.
Publicado: (2023)

Computational design of improved standardized chemotherapy protocols for grade II oligodendrogliomas
por: Pérez-García, Víctor M., et al.
Publicado: (2019)

Long-term follow up of patients with WHO grade 2 oligodendroglioma
por: Carstam, Louise, et al.
Publicado: (2023)

Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
por: Yang, Xiefeng, et al.
Publicado: (2022)

Synchronous supratentorial and infratentorial oligodendrogliomas with incongruous IDH1 mutations, a case report
por: Agopyan-Miu, Alexander H. C. W., et al.
Publicado: (2021)

Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study
por: Kang, Yu‐Mei, et al.
Publicado: (2019)

Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification
por: Ren, Tong, et al.
Publicado: (2016)

Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis
por: Du, Kaixin, et al.
Publicado: (2019)

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)

Gene Expression Profiling in Human High-Grade Astrocytomas
por: Liu, Zhongyu, et al.
Publicado: (2011)

Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis
por: Jungk, Christine, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mks4o54ojkprcc018em8cnbj5t